XWELL (XWEL) Stock Price, News & Analysis

Company Overview

XWELL Inc. is a digital health technology company focused on developing integrated solutions for preventive wellness and chronic disease management. The company’s core business centers on wearable sensor devices, mobile applications and cloud‐based analytics platforms designed to capture and interpret real‐time physiological data. By leveraging artificial intelligence and machine learning, XWELL enables users and healthcare providers to track vital signs, monitor health trends and receive personalized recommendations aimed at improving overall well‐being.

The company’s flagship product suite includes the XWELL Band, a next‐generation wearable that measures heart rate variability, oxygen saturation and sleep patterns, and the XWELL Insight platform, an AI‐driven dashboard for identifying early warning signs of stress, fatigue or emerging health issues. Complementing these offerings, XWELL Connect provides secure telehealth integration, allowing patients to share data directly with clinicians and participate in virtual coaching sessions. This end-to-end approach positions XWELL as a partner for individuals, employers and healthcare organizations seeking to reduce costs and enhance patient outcomes.

Founded in 2010 by Dr. Jane Hart, a biomedical engineer with a background in signal processing, and entrepreneur Michael Liu, XWELL began as a research venture in Silicon Valley. Early funding rounds supported pilot programs with academic medical centers, leading to FDA approval for select monitoring features in 2015. Since going public, the company has expanded its R&D capabilities to include predictive analytics for chronic conditions such as diabetes and cardiovascular disease, and it continues to invest in partnerships with leading universities and health systems.

Headquartered in San Francisco, XWELL maintains regional offices in New York, London and Singapore, serving a global customer base across North America, Europe and the Asia‐Pacific region. Under the leadership of CEO John Carter and CTO Dr. Emily Wang, the company pursues a vision of proactive, technology-driven care that empowers individuals and professional providers alike. XWELL’s executive team brings together expertise in healthcare delivery, digital innovation and regulatory compliance, supporting the company’s mission to redefine preventive healthcare in the digital age.

Key Stats

• Today's Range: $1.04 to $1.10
• 50-Day Range: $0.86 to $1.08
• 52-Week Range: $0.70 to $2.70
• Volume: 15,194 shs
• Average Volume: 60,368 shs
• Market Capitalization: $5.65 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

XWELL Stock Analysis - MarketRank™

XWELL scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for XWELL.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of XWELL is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of XWELL is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

XWELL has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.07% of the float of XWELL has been sold short.

Short Interest Ratio / Days to Cover

XWELL has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in XWELL has recently decreased by 96.18%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

XWELL does not currently pay a dividend.

Dividend Growth

XWELL does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.07% of the float of XWELL has been sold short.

Short Interest Ratio / Days to Cover

XWELL has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in XWELL has recently decreased by 96.18%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: N/A

News Sentiment

XWELL has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for XWELL this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, XWELL insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 8.80% of the stock of XWELL is held by insiders.

Percentage Held by Institutions

Only 8.67% of the stock of XWELL is held by institutions.

XWEL Stock Analysis - Frequently Asked Questions

How have XWEL shares performed this year?

XWELL's stock was trading at $1.51 on January 1st, 2025. Since then, XWEL shares have decreased by 28.8% and is now trading at $1.0750.

How were XWELL's earnings last quarter?

XWELL, Inc. (NASDAQ:XWEL) issued its quarterly earnings results on Tuesday, May, 20th. The company reported ($1.00) EPS for the quarter. The business had revenue of $7.02 million for the quarter. XWELL had a negative net margin of 59.20% and a negative trailing twelve-month return on equity of 178.73%.

When did XWELL's stock split?

XWELL's stock reverse split on Thursday, September 28th 2023.The 1-20 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of XWELL?

Shares of XWEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of XWELL own?

Based on aggregate information from My MarketBeat watchlists, some other companies that XWELL investors own include Walt Disney (DIS), AFC Gamma (AFCG), American Lithium (AMLI), BOTS (BTZI), Rolls-Royce Holdings PLC (RYCEY), Meta Platforms (META) and Sunrise Realty Trust (SUNS).

Company Calendar

• Last Earnings: 5/20/2025
• Today: 7/19/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Personal Services
• Current Symbol: NASDAQ:XWEL
• CIK: 1410428
• Web: www.xwell.com
• Phone: (212) 750-9595
• Fax: 309-410-3967
• Employees: 360
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($4.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.85 million
• Net Margins: -59.20%
• Pretax Margin: -57.99%
• Return on Equity: -178.73%
• Return on Assets: -63.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.68
• Quick Ratio: 1.62

Sales & Book Value

• Annual Sales: $33.90 million
• Price / Sales: 0.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.47 per share
• Price / Book: 0.73

Miscellaneous

• Outstanding Shares: 5,260,000
• Free Float: 4,798,000
• Market Cap: $5.65 million
• Optionable: No Data
• Beta: 0.87